Global Medical REIT (GMRE)
(Delayed Data from NYSE)
$8.09 USD
-0.07 (-0.86%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $8.09 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.09 USD
-0.07 (-0.86%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $8.09 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Zacks News
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
by Zacks Equity Research
Global Medical REIT (GMRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -4.17% and 8.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Global Medical REIT (GMRE) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Global Medical REIT (GMRE) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
City Office REIT (CIO) Q4 FFO Meet Estimates
by Zacks Equity Research
City Office REIT (CIO) delivered FFO and revenue surprises of 0% and 0.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Global Medical REIT (GMRE) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Plymouth Industrial (PLYM) Meets Q3 FFO Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of 0% and 1.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
CTO Realty (CTO) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
CTO Realty (CTO) delivered FFO and revenue surprises of 20% and 11.60%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Misses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -8% and 1.89%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alexander & Baldwin Holdings, Inc. (ALEX) Lags Q2 FFO Estimates
by Zacks Equity Research
Alexander & Baldwin Holdings, Inc. (ALEX) delivered FFO and revenue surprises of -3.33% and 8.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Misses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -8% and 0.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Healthpeak (PEAK) Q1 FFO Meet Estimates
by Zacks Equity Research
Healthpeak (PEAK) delivered FFO and revenue surprises of 0% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Global Medical REIT (GMRE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Global Medical REIT (GMRE) stock based on the movements in the options market lately.
Plymouth Industrial (PLYM) Q4 FFO and Revenues Lag Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of -2.22% and 3.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Life Storage (LSI) Stock Jumps 11.3%: Will It Continue to Soar?
by Zacks Equity Research
Life Storage (LSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock suggests that there could be more strength down the road.
Global Medical REIT (GMRE) Q3 FFO Lag Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -3.85% and 2.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GMRE or CUBE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMRE vs. CUBE: Which Stock Is the Better Value Option?
Global Medical REIT (GMRE) Q2 FFO Miss Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -3.85% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Summit Hotel Properties (INN) Misses Q2 FFO Estimates
by Zacks Equity Research
Summit Hotel Properties (INN) delivered FFO and revenue surprises of -6.90% and 5.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Douglas Emmett (DEI) Meets Q2 FFO Estimates
by Zacks Equity Research
Douglas Emmett (DEI) delivered FFO and revenue surprises of 0% and 2.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Corporate Office Properties (OFC) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Corporate Office Properties (OFC) delivered FFO and revenue surprises of 1.72% and 3.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SL Green (SLG) Q2 FFO Surpass Estimates
by Zacks Equity Research
SL Green (SLG) delivered FFO and revenue surprises of 10.65% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sunstone Hotel (SHO) Moves 8.4% Higher: Will This Strength Last?
by Zacks Equity Research
Sunstone Hotel (SHO) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.
Global Medical REIT (GMRE) Q1 FFO Lag Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of -7.69% and 4.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Community Healthcare Trust (CHCT) Beats Q1 FFO Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of 3.39% and 1.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Global Medical REIT (GMRE) Meets Q4 FFO Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0% and 0.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?